Farms.com Home   News

Spring 2018 Pulse Crop News

Welcome to the Spring 2018 issue of Pulse Crop News! Click here to view in Flipbook format or the links to individual stories below.


This issue contains features on protein supercluster funding, reduced chemistries, growing soybeans, cooking with aquafaba and more.

Chair’s Report – FarmTech: A Major Gathering Spot for Farmers
Executive Director’s Message – Facing Change & Challenges Head-On
New APG Board – Two New Directors Eager to Contribute to the Industry and Help Farmers
Policy Update – A Crash Course in Carbon Pricing, Markets and Offsets
Pulse Canada Update – Remaining GF2 Funds Help Pulse Canada Investigate New Markets for Pulses
Three Years of Growing Soybeans in Central Alberta
Industry Innovator Award – Dr. Hans-Henning Muendel Honoured as 2018 Recipient
New Research Officer Becomes Second PhD. on APG Staff
Reduced Chemistries – Pest Management Regulatory Agency (PMRA) Re-Evaluation Decisions & Lack of Pest Management Tools
Agsafe Alberta – Farm Safety Initiatives Making Headway
Pulses a Key Focus for Crop Protein Supercluster
APG Reports on Year 1 Learnings of the  Plot to Field Program
Chuck Penner: Will Canada Ever Export Pulses to India Again?
China: From Farm to Chopsticks

Source : Albertapulse

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.